Wave Crossover ECP Study for Simplified Therapy

Inclusion Criteria: * Age 35 years or greater * History of mild to moderate coronary artery disease (CAD) * Able to ambulate without assistance * Able to lay down (approximately 5 degree angle) for the duration of study procedures * Able and willing to give informed consent * Able and willing to attend the ECP session and complete all questionnaires provided Exclusion Criteria: * Unstable angina within prior 3 months * Canadian Cardiovascular Society (CCS) Class III or IV Angina * Moderate to severe peripheral arterial disease (PAD) * Myocardial infarction in the past 3 months * Coronary artery bypass grafting (CABG) in the past 3 months * Any major surgery within the past 3 months * Decompensated heart failure * Cardiac catheterization or arterial femoral puncture in the past 2 weeks * Presence of mechanical circulatory support (MCS) device * Pacemaker or other implantable pulse generating device * Valve disease, including aortic insufficiency * Abdominal or thoracic aortic dissection or aortic/cerebral aneurysms requiring clinical intervention * Severe pulmonary disease * Bleeding diathesis * Active thrombophlebitis * Uncontrolled hypertension (greater than 180/110 mmHg) * Baseline heart rate greater than 120 beats per minute or below 40 beats per minute * Arrhythmia and/or abnormal heart rhythm * Major hand injuries or amputation that would interfere with fingertip PPG * Unhealed wounds/fractures below the waist or lower limb amputation , general lower body musculoskeletal injuries * Vascular stents (arterial/venous) or orthopedic implants in the lower limbs * Currently undergoing ECP treatment * Pregnancy * Currently participating in any other clinical study of an investigational device or drug where treatment has not yet been completed * Participants with coagulopathy (PT-INR\>2.5) or taking blood thinners (e.g., warfarin) * Any medical condition that, in the opinion of the principal investigator (PI), would present undue risk to the participant